How Does Tremfya Work for Crohn's Disease? Tremfya is a type of medicine called a monoclonal antibody. It works by targeting a protein in your body called interleukin-23 (IL-23). IL-23 is a ...

Chronic inflammation, seen in Crohn’s disease and ulcerative colitis, can suppress a group of enzymes called CYP450. Some medicines are metabolized by these enzymes.

A new Crohn’s treatment that involves guselkumab showed outstandingly greater rates of endoscopic improvement, which are vital for reducing long-term complications.

In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that ...

A new study led by researchers at Mount Sinai Health System has identified distinct biological signatures in patients with ...

TREMFYA’s success in addressing significant unmet needs in Crohn’s disease represents a pivotal advancement, aligning with Johnson & Johnson’s commitment to improving outcomes for patients ...

Intravenous induction followed by subcutaneous maintenance therapy with guselkumab is efficacious for adults with moderately ...

IgG-seq identifies enteric bacteria recognized by serum IgG. Credit: Gut Microbes (2025). DOI: 10.1080/19490976.2025.2464221 ...

Health and Medicine; Targeted mRNA Therapy Holds Promise for Crohn’s Disease, Colitis, and Beyond. By. Pesach Benson / TPS - 29 Tevet 5785 – January 29, 2025. 0. Share on Facebook.

ALBUQUERQUE, N.M. — Crohn's disease is a serious long-term condition affecting hundreds of thousands of people in this country and gets a lot of attention at the University of New Mexico Hospital.

People with Crohn’s disease and related joint inflammation linked to immune system dysfunction have distinct gut bacteria or microbiota, with the bacterium Mediterraneibacter gnavus being a ...